Operating Margin of Cidara Therapeutics, Inc. from 31 Dec 2022 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cidara Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2022 to 31 Mar 2025.
  • Cidara Therapeutics, Inc. Operating Margin for the quarter ending 31 Mar 2025 was -63851%, a 3179% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Operating Margin for 2024 was -13812%, a 11784% decline from 2023.
  • Cidara Therapeutics, Inc. annual Operating Margin for 2023 was -116%, a 124% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Cidara Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -63851% -65924% -3179% 01 Jan 2025 31 Mar 2025
Q4 2024 -13812% -13696% -11784% 01 Oct 2024 31 Dec 2024
Q3 2024 886% +930% 01 Jul 2024 30 Sep 2024
Q2 2024 1922% +1926% 01 Apr 2024 30 Jun 2024
Q1 2024 2074% +2088% 01 Jan 2024 31 Mar 2024
Q4 2023 -116% -64% -124% 01 Oct 2023 31 Dec 2023
Q3 2023 -43% 01 Jul 2023 30 Sep 2023
Q2 2023 -4% 01 Apr 2023 30 Jun 2023
Q1 2023 -15% 01 Jan 2023 31 Mar 2023
Q4 2022 -52% 01 Oct 2022 31 Dec 2022

Cidara Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -13812% -13696% -11784% 01 Jan 2024 31 Dec 2024
2023 -116% -64% -124% 01 Jan 2023 31 Dec 2023
2022 -52% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.